{"product_id":"cytarabine-injection-1000mg-multi-dose-bulk-vial-50-ml-rx","title":"Cytarabine Injection 1000 mg per 50 mL Multi-dose Vial  50 mL by Pfizer Injectables (RX)","description":"\u003ch4\u003eHigh-Potency \u003cstrong\u003eChemotherapy for Leukemia and Lymphoma | Hospital-Grade Multi-Dose Vial\u003c\/strong\u003e\n\u003c\/h4\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003e\u003cstrong\u003eCytarabine Injection 1000 mg per 50 mL by Pfizer Injectables\u003c\/strong\u003e is a hospital-trusted, prescription-only chemotherapy agent designed for precision dosing and broad-spectrum antineoplastic activity. Used as a cornerstone in the treatment of hematologic malignancies, this multi-dose vial delivers dependable, measurable, and cost-effective therapy for cancer centers and hospital pharmacies nationwide.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003ePrimary Indications\/Uses:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAcute Myeloid Leukemia (AML)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAcute Lymphocytic Leukemia (ALL)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eChronic Myelogenous Leukemia (CML) – Blast Phase\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNon-Hodgkin’s Lymphoma (NHL)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMeningeal Leukemia\/Lymphoma (CNS Prophylaxis or Treatment)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOther Physician-Guided Cancer Protocols\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eKey Features \u0026amp; Benefits:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eConcentrated 1000 mg Cytarabine in 50 mL Multi-Dose Vial\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEssential Chemotherapy Drug\u003c\/strong\u003e for Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), and Non-Hodgkin’s Lymphoma (NHL)\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile, Preservative-Free Hospital-Grade Solution\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTrusted by Oncologists and Cancer Centers Worldwide\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReliable, Consistent Dosing For IV, Subcutaneous, or Intrathecal Use\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eManufactured \u0026amp; Quality-Tested by Pfizer Injectables – Industry Leaders in Oncology Care\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eWhat is Cytarabine Injection?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCytarabine\u003c\/strong\u003e (also known as Ara-C) is a high-efficacy antimetabolite chemotherapeutic used primarily for the induction and consolidation treatment of hematologic cancers. It works by disrupting DNA synthesis, effectively targeting rapidly dividing cancer cells in the bone marrow and blood.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eWho Uses Cytarabine?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCytarabine injection\u003c\/strong\u003e is prescribed for adults and pediatric oncology patients undergoing chemotherapy regimens for hematologic malignancies (blood cancers) under the direct supervision of a qualified healthcare professional. It is used in hospitals, infusion centers, and specialized oncology clinics worldwide.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eHow to Use (Administration):\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eFor Hospital and Clinical Use Only.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministered Only by Trained Medical Professionals\u003c\/strong\u003e via \u003cstrong\u003eintravenous (IV) infusion\u003c\/strong\u003e, \u003cstrong\u003esubcutaneous injection\u003c\/strong\u003e, or \u003cstrong\u003eintrathecal (spinal) injection\u003c\/strong\u003e, depending on the specific treatment protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing is individualized\u003c\/strong\u003e based on treatment phase, patient body surface area, and combination with other chemotherapy drugs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eDo not self-administer. Strictly follow institutional protocols and oncologist instructions.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eProduct Category:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eCytotoxic Chemotherapy Agent\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAntimetabolite Cancer Drug\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOncology\/Antineoplastic Medication\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrescription-Only Hospital Injectable\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eImportant Safety Information – Side Effects:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Nausea, vomiting, diarrhea, mouth sores (mucositis), low blood cell counts (anemia, leukopenia, thrombocytopenia), hair loss.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious Side Effects:\u003c\/strong\u003e Severe bone marrow suppression (risk of infection, bleeding), neurotoxicity, liver toxicity, pulmonary toxicity, allergic reactions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Regular blood tests and oncologist follow-up are required during therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarning:\u003c\/strong\u003e Use only under strict medical supervision with regular lab and clinical monitoring. Not for use outside a hospital or supervised clinical setting.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eWhy Choose Cytarabine Injection by Pfizer Injectables?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInternational Oncology Standard:\u003c\/strong\u003e Trusted for decades in hematology-oncology practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile, Stable Multi-Dose Vial:\u003c\/strong\u003e Ideal for hospital\/clinical pharmacy use.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBatch-Tested for Purity, Potency \u0026amp; Consistency\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreferred by Oncologists:\u003c\/strong\u003e Part of leading evidence-based leukemia and lymphoma protocols.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBacked by Pfizer’s Expertise in Injectable Oncology Therapy\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePfizer Cytarabine Injection 1000 mg\/50 mL: The Gold Standard Chemotherapy for AML, ALL, CML, and Lymphoma.\u003c\/strong\u003e \u003cstrong\u003eOrder for your hospital or clinic today—trusted, reliable, and ready for critical cancer care.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Pfizer Injectables","offers":[{"title":"Default Title","offer_id":53335142269246,"sku":"61703-0303-46","price":5485.99,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0872\/3408\/5182\/files\/Cytarabine-Injection-1000-mg-per-50-mL-Multi-dose-Vial--50-mL-by-Pfizer-Injectables-61703-0303-46.jpg?v=1776752236","url":"https:\/\/himkhand.com\/products\/cytarabine-injection-1000mg-multi-dose-bulk-vial-50-ml-rx","provider":"Himkhand","version":"1.0","type":"link"}